Results 111 to 120 of about 39,839 (224)

Two-year disease remission of an unresectable basaloid thymic carcinoma with second line chemotherapy drugs: report of a case

open access: yesThe Pan African Medical Journal, 2019
Thymic carcinomas are extremely infrequent neoplasms (15% of all thymic epithelial tumors). Basaloid carcinoma is a peculiar tumor that represents no more than 2% of those infrequent thymic carcinomas. Surgical excision is the recommended treatment.
Agustín Buero   +3 more
doaj   +1 more source

Thymic carcinoma vs. thymic neuroendocrine tumor

open access: yesMediastinum, 2018
Thymic neoplasm is a rare disease, accounting for
Samina Park, Young Tae Kim
openaire   +1 more source

A Rare Tumor with a Very Rare Initial Presentation: Thymic Carcinoma as Bone Marrow Metastasis

open access: yesCase Reports in Pathology, 2017
Tumors of thymus gland are rare and account for 0.2% to 1.5% of all the neoplasms. They constitute a heterogeneous group that has an unknown etiology and a complex as well as varied biology. This has led to difficulty in their histological classification
Sonam Sharma, Leelavathi Dawson
doaj   +1 more source

Thymic carcinomas

open access: yes, 2018
Thymic carcinomas (TC) are approximately 10 times less prevalent than thymomas but of high clinical relevance because they are more aggressive, less frequently resectable than thymomas and usually refractory to classical and targeted long-term treatment approaches.
Stroebel, Philipp, Weis, C.-A., Marx, A.
openaire   +1 more source

A rare case of tumor‐to‐tumor metastasis from thymic carcinoma to an ovarian mature teratoma

open access: yesThoracic Cancer
Metastasis from one neoplasm to another is referred to as tumor‐to‐tumor metastasis (TTM). TTM is rarely observed. Here, we present a patient with TTM from a thymic carcinoma to an ovarian mature teratoma. A 25‐year‐old woman, diagnosed with unresectable
Tsuyoshi Sasada   +4 more
doaj   +1 more source

A Case of Cervico-Mediastinal Thymic Cyst Causing Tracheal Compression in a Child [PDF]

open access: yes, 2020
Khan, Abdul Wasay   +4 more
core   +2 more sources

Investigating the impact of tumor size on survival outcomes in thymoma and thymic carcinoma patients using the SEER database

open access: yesScientific Reports
This study aims to clarify the impact of tumor size on the prognosis of patients diagnosed with thymoma and thymic carcinoma, leveraging data from a population-based registry.
Yipeng Yin   +3 more
doaj   +1 more source

Definitive chemoradiotherapy with Carboplatin Plus Paclitaxel for Unresectable Locally Advanced Thymic Carcinoma: A case series

open access: yesCurrent Problems in Cancer: Case Reports
Objectives: Thymic carcinoma (TC) is rare. There is no evidence regarding the treatment strategies for unresectable locally advanced thymic carcinomas. Definitive chemoradiotherapy may treat this condition. However, an appropriate concurrent chemotherapy
Koichiro Nozaki   +4 more
doaj   +1 more source

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies. [PDF]

open access: yes, 2018
Treatment options for high grade urothelial cancers are limited and have remained largely unchanged for several decades. Selinexor (KPT-330), a first in class small molecule that inhibits the nuclear export protein XPO1, has shown efficacy as a single ...
Baek, Han Bit   +14 more
core   +1 more source

Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases

open access: yesTherapeutic Advances in Medical Oncology
Background: Although immune checkpoint inhibitor treatment for advanced thymic carcinoma exhibits promising efficacy, factors that affect the efficacy and prognosis, including metastases sites, remain uncertain. Objectives: Our study aimed to investigate
Yue Hao   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy